Asset Management Ventures

Founded in 1965, Asset Management Company specializes in early stage information technology and life science investments. It has invested in more than 250 companies. Asset Management Company invests in the biotechnology and small molecule therapeutics, cell therapy, analytical instrumentation and convergent technologies, and medical devices and equipment sectors. It also offers services to the information technology, electronic design automation, wireless and mobility, hardware, nanotechnology, and enterprise and application software sectors. Asset Management Company s clients include Amgen, BiPar Sciences, Celera Genomics, Chimerix, CV Therapeutics, Biogen IDEC, InteKrin Therapeutics, Koronis Pharmaceuticals and Pharmacyclics. Asset Management Company also serves Biomimedica, Capnia, Coapt Systems, EndoVx, Fusion Medical Technologies and iScience Interventional.